MHRA Issues Urgent Safety Warning Over Rare Cases of Iatrogenic Botulism Linked to Botulinum Toxin Type A Injections
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a critical safety communication regarding the administration of botulinum toxin…